Although the effects of AXT on GBM remain relatively unknown, in addition to the evidence obtained from the other cancer cell lines mentioned above, the manipulation of redox homeostasis has already been shown to be an effective strategy for triggering apoptosis in GBM cells [20], suggesting that AXT has potential as a novel GBM treatment. Here, CNTN2 is linked to cancer.